Gentisein
Based on 1 Customer Validation
Gentisein (NSC 329491), the major metabolite of Mangiferin, shows the most potent serotonin uptake inhibition with an IC50 value of 4.7 µM.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 98.07%
- No. CAS: 529-49-7
- Fòrmula: C13H8O5
- Peso molecular:244.20
-
Almacenamiento:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Ver todos los productos específicos de isoformas 5-HT Receptor
More
Actividad biológica
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
146.35 μM
Compound: 3
|
Cytotoxicity against Taxol-resistant human A549 cells measured after 48 hrs by MTT assay
Cytotoxicity against Taxol-resistant human A549 cells measured after 48 hrs by MTT assay
|
[PMID: 28065566] |
| COLO 320 | IC50 |
>200 μM
Compound: 45378
|
Antiproliferative activity against human COLO320 cells after 48 hrs by CCK8 assay
Antiproliferative activity against human COLO320 cells after 48 hrs by CCK8 assay
|
[PMID: 28376372] |
| HeLa S3 | IC50 |
>10 μM
Compound: 20
|
Cytotoxicity in human HeLaS3 cells incubated for 72 hrs by MTT assay
Cytotoxicity in human HeLaS3 cells incubated for 72 hrs by MTT assay
|
[PMID: 30978023] |
| HepG2 | IC50 |
>100 μM
Compound: 1f
|
Cytotoxicity against human HepG2 cells assessed as NADH level after overnight incubation by MTS assay
Cytotoxicity against human HepG2 cells assessed as NADH level after overnight incubation by MTS assay
|
[PMID: 22537683] |
| HepG2 | IC50 |
>200 μM
Compound: 45378
|
Antiproliferative activity against human HepG2 cells after 48 hrs by CCK8 assay
Antiproliferative activity against human HepG2 cells after 48 hrs by CCK8 assay
|
[PMID: 28376372] |
| HepG2 | IC50 |
>200 μM
Compound: 2c
|
Growth inhibition of human HepG2 cells after 24 hrs by MTT assay
Growth inhibition of human HepG2 cells after 24 hrs by MTT assay
|
[PMID: 29609121] |
| HepG2 | IC50 |
18.3 μM
Compound: Table S1, R266C2
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 30684866] |
| HepG2 | IC50 |
>10 μM
Compound: 20
|
Cytotoxicity in human HepG2 cells incubated for 72 hrs by MTT assay
Cytotoxicity in human HepG2 cells incubated for 72 hrs by MTT assay
|
[PMID: 30978023] |
| HT-29 | IC50 |
>10 μM
Compound: 20
|
Cytotoxicity in human HT-29 cells incubated for 72 hrs by MTT assay
Cytotoxicity in human HT-29 cells incubated for 72 hrs by MTT assay
|
[PMID: 30978023] |
| Jurkat | IC50 |
>100 μM
Compound: 1f
|
Cytotoxicity against human Jurkat T cells assessed as NADH level after overnight incubation by MTS assay
Cytotoxicity against human Jurkat T cells assessed as NADH level after overnight incubation by MTS assay
|
[PMID: 22537683] |
| K562 | IC50 |
105.6 μM
Compound: 45378
|
Antiproliferative activity against human K562 cells after 48 hrs by CCK8 assay
Antiproliferative activity against human K562 cells after 48 hrs by CCK8 assay
|
[PMID: 28376372] |
| KB | IC50 |
>10 μM
Compound: 20
|
Cytotoxicity in human KB cells incubated for 72 hrs by MTT assay
Cytotoxicity in human KB cells incubated for 72 hrs by MTT assay
|
[PMID: 30978023] |
| MCF7 | IC50 |
31.2 μM
Compound: 45378
|
Antiproliferative activity against human MCF7 cells after 48 hrs by CCK8 assay
Antiproliferative activity against human MCF7 cells after 48 hrs by CCK8 assay
|
[PMID: 28376372] |
| MCF7 | IC50 |
>200 μM
Compound: 2c
|
Growth inhibition of human MCF7 cells after 24 hrs by MTT assay
Growth inhibition of human MCF7 cells after 24 hrs by MTT assay
|
[PMID: 29609121] |
| MCF7 | IC50 |
>10 μM
Compound: 20
|
Cytotoxicity in human MCF7 cells incubated for 72 hrs by MTT assay
Cytotoxicity in human MCF7 cells incubated for 72 hrs by MTT assay
|
[PMID: 30978023] |
| MDA-MB-231 | IC50 |
25.1 μM
Compound: 45378
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by CCK8 assay
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by CCK8 assay
|
[PMID: 28376372] |
| MDA-MB-231 | IC50 |
>200 μM
Compound: 2c
|
Growth inhibition of human MDA-MB-231 cells after 24 hrs by MTT assay
Growth inhibition of human MDA-MB-231 cells after 24 hrs by MTT assay
|
[PMID: 29609121] |
| NCI/ADR-RES | IC50 |
192.66 μM
Compound: 3
|
Cytotoxicity against human MCF7/ADR cells measured after 48 hrs by MTT assay
Cytotoxicity against human MCF7/ADR cells measured after 48 hrs by MTT assay
|
[PMID: 28065566] |
| SMMC-7721 | IC50 |
38.52 μM
Compound: 3
|
Cytotoxicity against Taxol-resistant human SMMC7721 cells measured after 48 hrs by MTT assay
Cytotoxicity against Taxol-resistant human SMMC7721 cells measured after 48 hrs by MTT assay
|
[PMID: 28065566] |
Chemical Information
-
No. CAS 529-49-7
-
Appearance Solid
-
Peso molecular 244.20
-
Fòrmula C13H8O5
-
Color Light yellow to yellow
-
SMILES
O=C1C2=C(C=C(C=C2O)O)OC3=C1C=C(C=C3)O
-
Synonyms
NSC 329491; 1,3,7-Trihydroxyxanthone
-
Structure Classification
-
Initial Source
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Solvente y solubilidad
DMSO : 100 mg/mL (409.50 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureza y Documentación
-
Ficha de datos (269 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.0950 mL | 20.4750 mL | 40.9500 mL | 102.3751 mL |
| 5 mM | 0.8190 mL | 4.0950 mL | 8.1900 mL | 20.4750 mL | |
| 10 mM | 0.4095 mL | 2.0475 mL | 4.0950 mL | 10.2375 mL | |
| 15 mM | 0.2730 mL | 1.3650 mL | 2.7300 mL | 6.8250 mL | |
| 20 mM | 0.2048 mL | 1.0238 mL | 2.0475 mL | 5.1188 mL | |
| 25 mM | 0.1638 mL | 0.8190 mL | 1.6380 mL | 4.0950 mL | |
| 30 mM | 0.1365 mL | 0.6825 mL | 1.3650 mL | 3.4125 mL | |
| 40 mM | 0.1024 mL | 0.5119 mL | 1.0238 mL | 2.5594 mL | |
| 50 mM | 0.0819 mL | 0.4095 mL | 0.8190 mL | 2.0475 mL | |
| 60 mM | 0.0683 mL | 0.3413 mL | 0.6825 mL | 1.7063 mL | |
| 80 mM | 0.0512 mL | 0.2559 mL | 0.5119 mL | 1.2797 mL | |
| 100 mM | 0.0410 mL | 0.2048 mL | 0.4095 mL | 1.0238 mL |